To obtain additional safety data in subjects who have previously completed the MBP8298-01
study "A Double Blind Placebo Controlled Multi-Centre to Evaluate the Efficacy and Safety of
MBP8298 in Subjects with Secondary Multiple Sclerosis" Dirucotide is generic name for
MBP8298.